5376 - 5400 of 6255 Results
Title
Year
- The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP12018OPENTitle: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00064Best OA location URL: https://pub.dzne.de/record/139819Citation Count: 37
- Identification of N-linked glycans as specific mediators of neuronal uptake of acetylated α-Synuclein2019OPENTitle: Identification of N-linked glycans as specific mediators of neuronal uptake of acetylated α-SynucleinJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 6Start Page: e3000318End Page: e3000318Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3000318Best OA location URL: https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3000318&type=printableCitation Count: 47
- A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage2025OPENTitle: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stageJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 213Issue #:Start Page: 107018End Page: 107018Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107018Citation Count: 0
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression2021OPENTitle: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2444End Page: 2446Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28715Best OA location URL: https://doi.org/10.1002/mds.28715Citation Count: 49
- The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human2018OPENTitle: The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and humanJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 11Start Page: 1861End Page: 1883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20180248Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/11/1861/691623/bcj-2018-0248.pdfCitation Count: 198
- The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A2019OPENTitle: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 13Start Page: 4738End Page: 4758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra118.005008Best OA location URL: http://www.jbc.org/article/S0021925820355307/pdfCitation Count: 69
-
OPENTitle: Cell-free RNA signatures predict Alzheimer’s diseaseJournal Name: iSciencePublisher: Elsevier BVVol: 26Issue #: 12Start Page: 108534End Page: 108534Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2023.108534Best OA location URL: https://doi.org/10.1016/j.isci.2023.108534Citation Count: 6
- A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s disease2021OPENTitle: A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 7Start Page: e0254834End Page: e0254834Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0254834Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0254834&type=printableCitation Count: 11
-
OPENTitle: Resolving inter-regional communication capacity in the human connectomeJournal Name: Network NeurosciencePublisher: MIT PressVol: 7Issue #: 3Start Page: 1051End Page: 1079Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1162/netn_a_00318Best OA location URL: https://direct.mit.edu/netn/article-pdf/doi/10.1162/netn_a_00318/2078941/netn_a_00318.pdfCitation Count: 2
-
OPENTitle: ATP and NAD+ Deficiency in Parkinson’s DiseaseJournal Name: NutrientsPublisher: MDPI AGVol: 15Issue #: 4Start Page: 943End Page: 943Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu15040943Best OA location URL: https://www.mdpi.com/2072-6643/15/4/943/pdf?version=1676358966Citation Count: 25
-
OPENTitle: A comparison of publicly available linear MRI stereotaxic registration techniquesJournal Name: NeuroImagePublisher: Elsevier BVVol: 174Issue #:Start Page: 191End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.03.025Citation Count: 146
-
OPENTitle: Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral SclerosisJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2017.00216Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2017.00216/pdfCitation Count: 24
- A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein2018OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 52
- Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers2023OPENTitle: Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 11Start Page: e95End Page: e97Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad169Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad169/50433441/awad169.pdfCitation Count: 10
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein2016OPENTitle: A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s13024-016-0125-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0125-0Citation Count: 38
-
OPENTitle: Structure-based design and characterization of Parkin-activating mutationsJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 6Issue #: 6Start Page: e202201419End Page: e202201419Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202201419Best OA location URL: https://www.life-science-alliance.org/content/lsa/6/6/e202201419.full.pdfCitation Count: 23
- Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease2020OPENTitle: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 43Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aaz9360Best OA location URL: https://advances.sciencemag.org/content/advances/6/43/eaaz9360.full.pdfCitation Count: 282
- Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes2019OPENTitle: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 768End Page: 773Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2018-320151Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/7/768.full.pdfCitation Count: 49
-
OPENTitle: Deep gray matter volume loss drives disability worsening in multiple sclerosisJournal Name: Annals of NeurologyPublisher: WileyVol: 83Issue #: 2Start Page: 210End Page: 222Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ana.25145Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/e17312df-ef70-416a-a782-0c33bcbef599Citation Count: 374
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesia2017OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 40
- Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein2022OPENTitle: Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-SynucleinJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 94Issue #: 48Start Page: 16711End Page: 16719Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.2c03183Best OA location URL: https://doi.org/10.1021/acs.analchem.2c03183Citation Count: 18
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup2024OPENTitle: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page: 5143End Page: 5169Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13859Best OA location URL: https://hdl.handle.net/11380/1365841Citation Count: 616
- Ultra‐low‐dose PET reconstruction using generative adversarial network with feature matching and task‐specific perceptual loss2019OPENTitle: Ultra‐low‐dose PET reconstruction using generative adversarial network with feature matching and task‐specific perceptual lossJournal Name: Medical PhysicsPublisher: WileyVol: 46Issue #: 8Start Page: 3555End Page: 3564Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mp.13626Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6692211Citation Count: 159
- M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder2019OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6555658Citation Count: 33
-
OPENTitle: Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00172-zBest OA location URL: https://www.nature.com/articles/s41531-021-00172-z.pdfCitation Count: 21